News Release

World Orphan Drug Congress

Title :World Orphan Drug Congress
Date :September 15, 2011
Location :Seoul, Korea
Description :Dr. Ying Luo to introduce the development of F647 for idiopathic pulmonary fibrosis.

China SFDA Approves F647／Pirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis
（Added）Notice for Acquisition of Beijing Continent Pharmaceutical Co. Ltd.